Zhejiang Yatai Pharmaceutical Co Ltd Net Asset Quality Index
Zhejiang Yatai Pharmaceutical Co Ltd net asset quality index. Zhejiang Yatai Pharmaceutical Co Ltd (002370) has a Net Asset Quality Index of 90.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.23 Billion minus total liabilities of CN¥115.18 Million yields net assets of CN¥1.12 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Zhejiang Yatai Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zhejiang Yatai Pharmaceutical Co Ltd (2006–2025)
Net asset quality index of Zhejiang Yatai Pharmaceutical Co Ltd from 2006 to 2025. This chart shows how Zhejiang Yatai Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 90.7%, representing net assets of CN¥1.12 Billion against total assets of CN¥1.23 Billion CNY. Check strategic asset allocation of Zhejiang Yatai Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Zhejiang Yatai Pharmaceutical Co Ltd Net Asset Quality Index by Year (2006–2025)
Zhejiang Yatai Pharmaceutical Co Ltd net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhejiang Yatai Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002370 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.5% | CN¥1.12 Billion | CN¥1.28 Billion | CN¥159.43 Million | ▲ +18.2 pp |
| 2024 | 69.4% | CN¥972.18 Million | CN¥1.40 Billion | CN¥429.59 Million | ▲ +28.7 pp |
| 2023 | 40.6% | CN¥580.87 Million | CN¥1.43 Billion | CN¥848.50 Million | ▲ +20.9 pp |
| 2022 | 19.8% | CN¥301.22 Million | CN¥1.52 Billion | CN¥1.22 Billion | ▼ -7.1 pp |
| 2021 | 26.9% | CN¥432.96 Million | CN¥1.61 Billion | CN¥1.18 Billion | ▼ -6.9 pp |
| 2020 | 33.8% | CN¥660.41 Million | CN¥1.96 Billion | CN¥1.30 Billion | ▲ +5.8 pp |
| 2019 | 27.9% | CN¥633.06 Million | CN¥2.27 Billion | CN¥1.64 Billion | ▼ -39.2 pp |
| 2018 | 67.2% | CN¥2.38 Billion | CN¥3.54 Billion | CN¥1.16 Billion | ▼ -12.8 pp |
| 2017 | 80.0% | CN¥2.28 Billion | CN¥2.85 Billion | CN¥569.62 Million | ▼ -9.1 pp |
| 2016 | 89.1% | CN¥2.17 Billion | CN¥2.43 Billion | CN¥265.69 Million | ▲ +50.6 pp |
| 2015 | 38.5% | CN¥793.15 Million | CN¥2.06 Billion | CN¥1.27 Billion | ▼ -49.6 pp |
| 2014 | 88.1% | CN¥747.31 Million | CN¥848.53 Million | CN¥101.21 Million | ▼ -0.5 pp |
| 2013 | 88.5% | CN¥709.83 Million | CN¥801.86 Million | CN¥92.04 Million | ▲ +2.5 pp |
| 2012 | 86.1% | CN¥703.94 Million | CN¥818.02 Million | CN¥114.08 Million | ▲ +0.6 pp |
| 2011 | 85.5% | CN¥745.30 Million | CN¥871.78 Million | CN¥126.48 Million | ▲ +2.3 pp |
| 2010 | 83.2% | CN¥719.95 Million | CN¥864.98 Million | CN¥145.02 Million | ▲ +31.2 pp |
| 2009 | 52.0% | CN¥229.79 Million | CN¥441.87 Million | CN¥212.08 Million | ▲ +3.5 pp |
| 2008 | 48.5% | CN¥198.69 Million | CN¥409.54 Million | CN¥210.84 Million | ▲ +4.9 pp |
| 2007 | 43.6% | CN¥157.93 Million | CN¥362.44 Million | CN¥204.51 Million | ▼ -1.4 pp |
| 2006 | 45.0% | CN¥144.78 Million | CN¥321.94 Million | CN¥177.15 Million | — |